christopher pechock  independent director  myos rens technology inc myos our partners contact us menu christopher pechock  independent director christopher pechock joined us as a director in february  mr pechock has been a partner at matlin patterson global advisers a global alternative asset manager since its inception in july  from november  to july  mr pechock served as a member of the global distressed securities group credit suisse nysecs from january  to october  mr pechock served as a portfolio manager and research analyst at turnberry capital management lp prior to that mr pechock served as a portfolio manager at eos partners lp february  to december  a vice president and high yield analyst at painewebber inc may  to january  and an analyst in risk arbitrage at wertheim schroder  co incorporated august  to april  he serves on the board of directors of gleacher  company inc nasdaq glch and oceanus llc a private shipowning company mr pechock received a ba in economics from the university of pennsylvania and an mba from the columbia university graduate school of business we believe mr pechock’s extensive financial background qualifies him to serve on our board of directors search our site contact us myos rens technology incmorris technical center horsehill road suite cedar knolls nj   investor relationsmyos rens technology inc  christopher robert pechock  far hills nj  company information products resources my account talk to a db advisor  business directory nj far hills business services nec business services at noncommercial site christopher robert pechock c christopher robert pechock claim this business  winston farm ln far hills nj 7 get directions business info founded  incorporated annual revenue  employee count  industries business services at noncommercial site contacts  contact business your email address subject message send message company summary since  christopher robert pechock has been providing business services at noncommercial site from far hills christopher robert pechock has estimated annual revenues of  and also employs an estimated  employees verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   c view additional data select from over  networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocal7com mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call  to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc 7 all rights reserved myos corporation appoints christopher pechock to its board of directorshomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets closedsp 7 dow 77 nasdaq7 listenaetnas ceo mark bertolini on the future of the health care systembertolini shares how a lifethreatening injury shaped his views on health caremyos corporation appoints christopher pechock to its board of directorsmarketwiredfebruary  reblogsharetweetsharecedar knolls njmarketwired  feb    myos corporation  otcbb  myos  an emerging biotherapeutics and bionutrition company focused on the discovery development and commercialization of products that improve human muscle health and performance myos or the company announced today that it has appointed christopher pechock to its board of directorschris brings broad experience to myos having built an exceptional track record during his career at a number of notable investment firms on wall street and has built a strong reputation in guiding a wide range of developing and growing companies we believe his diverse expertise and extensive network will be invaluable to myos during this important stage in the companys history chris is a thoughtful and creative advisor and on behalf of the board of directors and management i would like to welcome him to the myos team stated robert j hariri md phd chairman of the board of myos corporationi believe myos is poised to become a leader in the field of muscle health commented mr pechock the company has an innovative and exciting business strategy that can maximize the probability of success as an emerging biotherapeutics and bionutrition business given the companys growing consumer presence with leading sports nutrition products i believe myos is perfectly positioned to apply its technology beyond the current bionutrition market to treat muscle loss associated with aging chronic illness and a range of unmet medical needs i am thrilled to be part of the team during this exciting timemr pechock brings to myos more than  years of wall street experience as an investment banker buyside and sellside analyst and private equity professional mr pechock currently is a partner and chairman of the investment committee of matlin patterson global advisers prior to joining matlinpatterson at inception in july  mr pechock was a member of credit suisses global distressed securities group  prior to joining credit suisse mr pechock was a portfolio manager and research analyst in distressed securities at turnberry capital management lp  a portfolio manager in distressed securities and special situations at eos partners lp  a vice president and high yield analyst at painewebber inc  and an analyst in corporate finance and risk arbitrage at wertheim schroder  co incorporated  mr pechock holds an mba from the columbia university graduate school of business  and a ba in economics from the university of pennsylvania mr pechock serves on the boards of directors of oceanus llc and gleacher  company he previously served on various other boards including renewable biofuels comsys it compass aerospace goss international huntsman corporation xl health corporation leprechaun holding company fxi holdings icon health and fitness and spincycle incabout myos corporation myos is a developmental stage bionutrition and biotherapeutics company focused on the discovery development and commercialization of products that improve muscle health and function essential to the management of sarcopenia cachexia and degenerative muscle diseases myos is the owner of myot® the first clinically proven natural myostatin inhibitor myostatin is a natural regulatory protein which inhibits muscle growth and recovery medical literature suggests that lowering myostatin levels has many potential health benefits including increased muscle mass healthy weight management improved energy levels stimulation of muscle healing as well as treating sarcopenia a condition of agerelated loss of muscle mass for more information on myot and to discover why myos is known as the muscle company™ visit wwwmyoscorpcomthe companys first commercial product myox™ powered by myot® is distributed by maximum human performance mhp and is currently available on popular retailer websites including wwwmhpstrongcom wwwbodybuildingcom and in specialty retailers including gnc and vitamin shoppe and others myos believes that myox as well as future products it envisions will redefine existing standards for muscle healthread moreforwardlooking statements any statements in this release that are not historical facts are forwardlooking statements actual results may differ materially from those projected or implied in any forwardlooking statements such statements involve risks and uncertainties including but not limited to those relating to the successful continued research of myot® and its effects on myostatin inhibition including our research and development activities product and customer demand the continued growth of repeat purchases market acceptance of our products the ability to create new products through research and development the continued growth in market expansion and revenue the successful entry into new markets the ability to attract additional investors and increase shareholder value the ability to generate the forecasted revenue stream and cash flow from sales of myox the ability to achieve a sustainable profitable business the effect of economic conditions the ability to protect our intellectual property rights the continued growth and expansion of myox in gnc vitamin shoppe and other specialty retail stores the ability to strengthen our manufacturing relationships and reduce the costs of our products competition from other providers and products risks in product development our ability to raise capital to fund continuing operations and other factors discussed from time to time in our securities and exchange commission filings we undertake no obligation to update or revise any forwardlooking statement for events or circumstances after the date on which such statement is made except as required by lawthese statements have not been evaluated by the food and drug administration this product is not intended to diagnose treat cure or prevent any diseasereblogsharetweetsharerecently viewedyour list is emptywhat to read nexthow  lifethreatening events changed how aetnas ceo views health careyahoo financewhy sparkling water sales could spike by  in 7yahoo financeamazon is going underwater seriouslyfortunea few things i learned about shorting the stock market for the first timestefan cheplicks tumblraetna ceo bertolini how tech plays into the future of healthcareyahoo finance videowhy it might be ‘dangerous’ for ibm to turn itself around professoryahoo financesupreme court ruling leads to offensive trademark requestsreutersscaramucci quotes anonymous source on russian hacking then admits trump was the sourcebusiness insiderhow to save money when youre youngyahoo financegm to consider axing six models to combat slumping sales avoid plant layoffsthe streetaetna ceo bertolini why he pays his employees to sleepyahoo finance videocall of the week nows the time to buy chipotleyahoo financejeb bush calls out republicans who criticized obama over russia but have been silent on the trumprussia probebusiness insiderwhat its like to ship yourself overnight on cabins sleep pod bustechcrunchaetnas ceo mark bertolini on the future of the health care systemyahoo financestarbucks has a disturbing problem even its cheerleaders must admit this is a major issuethe streetthe attorney general just expanded a scary program that allows police to seize people’s cash and property without arrest or chargemysteriousdesertbeauty the nazis did this toojoin the conversation  7 myos appoints christopher pechock to its board of directors employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       myos myos appoints christopher pechock to its board of directors tweet  7 am cedar knolls njmarketwired  february    myos corporation otcbb myos an emerging biotherapeutics and bionutrition company focused on the discovery development and commercialization of products that improve human muscle health and performance myos or the company announced today that it has appointed christopher pechock to its board of directors chris brings broad experience to myos having built an exceptional track record during his career at a number of notable investment firms on wall street and has built a strong reputation in guiding a wide range of developing and growing companies we believe his diverse expertise and extensive network will be invaluable to myos during this important stage in the companys history chris is a thoughtful and creative advisor and on behalf of the board of directors and management i would like to welcome him to the myos team stated robert j hariri md phd chairman of the board of myos corporation i believe myos is poised to become a leader in the field of muscle health commented mr pechock the company has an innovative and exciting business strategy that can maximize the probability of success as an emerging biotherapeutics and bionutrition business given the companys growing consumer presence with leading sports nutrition products i believe myos is perfectly positioned to apply its technology beyond the current bionutrition market to treat muscle loss associated with aging chronic illness and a range of unmet medical needs i am thrilled to be part of the team during this exciting time mr pechock brings to myos more than  years of wall street experience as an investment banker buyside and sellside analyst and private equity professional mr pechock currently is a partner and chairman of the investment committee of matlin patterson global advisers prior to joining matlinpatterson at inception in july  mr pechock was a member of credit suisses global distressed securities group  prior to joining credit suisse mr pechock was a portfolio manager and research analyst in distressed securities at turnberry capital management lp  a portfolio manager in distressed securities and special situations at eos partners lp  a vice president and high yield analyst at painewebber inc  and an analyst in corporate finance and risk arbitrage at wertheim schroder  co incorporated  mr pechock holds an mba from the columbia university graduate school of business  and a ba in economics from the university of pennsylvania  mr pechock serves on the boards of directors of oceanus llc and gleacher  company he previously served on various other boards including renewable biofuels comsys it compass aerospace goss international huntsman corporation xl health corporation leprechaun holding company fxi holdings icon health and fitness and spincycle inc about myos corporation myos is a developmental stage bionutrition and biotherapeutics company focused on the discovery development and commercialization of products that improve muscle health and function essential to the management of sarcopenia cachexia and degenerative muscle diseases myos is the owner of myot® the first clinically proven natural myostatin inhibitor myostatin is a natural regulatory protein which inhibits muscle growth and recovery medical literature suggests that lowering myostatin levels has many potential health benefits including increased muscle mass healthy weight management improved energy levels stimulation of muscle healing as well as treating sarcopenia a condition of agerelated loss of muscle mass for more information on myot and to discover why myos is known as the muscle company™ visit wwwmyoscorpcom the companys first commercial product myox™ powered by myot® is distributed by maximum human performance mhp and is currently available on popular retailer websites including wwwmhpstrongcom wwwbodybuildingcom and in specialty retailers including gnc and vitamin shoppe and others myos believes that myox as well as future products it envisions will redefine existing standards for muscle health forwardlooking statements any statements in this release that are not historical facts are forwardlooking statements actual results may differ materially from those projected or implied in any forwardlooking statements such statements involve risks and uncertainties including but not limited to those relating to the successful continued research of myot® and its effects on myostatin inhibition including our research and development activities product and customer demand the continued growth of repeat purchases market acceptance of our products the ability to create new products through research and development the continued growth in market expansion and revenue the successful entry into new markets the ability to attract additional investors and increase shareholder value the ability to generate the forecasted revenue stream and cash flow from sales of myox the ability to achieve a sustainable profitable business the effect of economic conditions the ability to protect our intellectual property rights the continued growth and expansion of myox in gnc vitamin shoppe and other specialty retail stores the ability to strengthen our manufacturing relationships and reduce the costs of our products competition from other providers and products risks in product development our ability to raise capital to fund continuing operations and other factors discussed from time to time in our securities and exchange commission filings we undertake no obligation to update or revise any forwardlooking statement for events or circumstances after the date on which such statement is made except as required by law these statements have not been evaluated by the food and drug administration this product is not intended to diagnose treat cure or prevent any disease contactjenene thomasinvestor relations and corporate communications email contact help employers find you check out all the jobs and post your resume read at biospacecom related news myos myos board of directors issues letter to shareholders ariad pharmaceuticals inc aria brings in two activistbacked directors onto board of directors myos myos announces for reverse stock split following five consecutive quarters of market expansion and revenue growth biogen idec biib taps papadopoulos as its chairman replacing young myos myos closes  million private placement ucb inc ucbjfpk ceo out biopharma chief appointed to top post myos myos announces appointment of robert c ashton jr md as chief medical officer alchemia appoints thomas liquard as chief executive officer myos myos announces third quarter results  billion deal gives viropharma incorporated vphm execs huge paydays please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • myos   • biotechpharma  personnel                 myos christopher r pechock insider trades for myos rens technology inc bulletin investor alert tokyo markets close in currencies europe markets london markets expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close myos rens technology inc nasdaq myos go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus myos rens technology inc market closed  quotes are delayed by  min jul  7  pm myos quoteszigman77composite   change   volume volume  quotes are delayed by  min quoteszigman77composite previous close     change   day low day high    week low  week high   insider activity individual christopher r pechock mr christopher r pechock is partner at matlinpatterson global advisers llc and a manager at huntsman advanced materials llc he is on the board of directors at myos corp gleacher  co inc broadpoint securities inc gleacher  co llc and lepmed inc he joined matlinpatterson in july  mr pechock was previously employed as a memberdistressed group by credit suisse group ag a portfolio manager by turnberry capital management lp a portfolio manager by eos partners lp and vice president by painewebber inc he also served on the board at broadpoint securities group inc huntsman corp compass aerospace corp comsys information technology services inc fxi holdings inc goss international corp renewable biofuels inc and xlhealth corp mr pechock holds an mba from the columbia university graduate school of business  and a ba in economics from the university of pennsylvania  transactions date shares transaction value     award at  per share  copyright 7 factset research systems inc all rights reserved source factset fundamentals officers and executives mr ren ren cochairman dr robert joseph hariri gordon cochairman mr joseph manello chief executive officer  director mr joanne goodford managerfacility development  headoperations mr maghsoud dariani headscience  technology mr dominick commesso executive vice presidentsales  marketing mr joseph dipietro controller mr victor e mandel independent director mr bin zhou independent director mr john j nosta independent director mr christopher r pechock independent director dr louis j aronne independent director trending tickers quoteszigman77composite vuzi quoteszigman77composite jcp quoteszigmancomposite nugt quoteszigman7composite tlt quoteszigmancomposite jnug x powered by log in  pm edt july  7 marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest 7pat least  dead after overheated tractortrailer found outside texas walmart p‘full transparency’ doesn’t mean what scaramucci apparently thinks it means pstocks brace for volatility in earnings deluge fed meeting looms pthe dark side of cruises pif you suddenly quit your job like sean spicer here’s what you should do next pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pnever ever say these things to a coworker pmy uncle with dementia needs longterm care — should i refinance his house pthis is the deadliest time of your life to put on weight p easily avoidable reasons why millennials can’t have nice things or save any money pwhy house prices in gay neighborhoods are soaring pnearly  of adults don’t have life insurance — these startups are trying to change that pmarie kondo says this one thing could be holding you back from falling in love pthis luxury credit card is only for truly big spenders phow elon musk and shorter commutes could transform people’s lives pbanks have raised creditcard interest rates — but not savings account rates pthe most expensive city in the world is not new york or san francisco p in  americans say they will die in debt pshopping at costco and  other things that prove rich people are cheap aheavy showers swamp new orleans street with rainwater loading more headlines dow quoteszigman7realtime 7 7  nasdaq quoteszigmanrealtime 7   sp  quoteszigmanrealtime 7   kiosk 7 7 the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml 7   alerts congakioskalertshtml  77  virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml  7 77 location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml 7 7 7 lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright  7 marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice    forbidden access is denied server error   forbidden access is denied you do not have permission to view this directory or page using the credentials that you supplied   forbidden access is denied server error   forbidden access is denied you do not have permission to view this directory or page using the credentials that you supplied chris pechocks phone  address  peoplebyname contact login home people alphabetically p pechock chris pechock people directory with over  names record id 7chris pechock 7th stnew york ny  background check  available record id 7chris pechock south avenew canaan ct  background check  available record id 7chris r pechock rd stnew york ny age  born mar  background check  available record id 7chris r pechock michael rdmendham nj 7age  born  background check  available     7 total records available tweet testimonials read testimonials from real customers who already used our services read more webmasters earn  commission on every sale you drive to our website weekly payouts read more mobile version visit us from your smart phone anywhere you are read more recent lookups check out the most recent reverse phone lookups on peoplebynamecom read more home mobile version phone directory people directory remove information terms of service privacy policy affiliate program about us member login frequently asked questions contact us testimonials careers product  services volume discounts site map  peoplebyname all rights reserved 7